Arch Venture Fund VII LP Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arch Venture Fund VII LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arch Venture Fund VII LP. Arch Venture Fund VII LP is 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in Receptos, Inc. ($RCPT) and 10% Owner in 908 Devices Inc. ($MASS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Juno Therapeutics, Inc. ($JUNO) and 10% Owner in Sage Therapeutics, Inc. ($SAGE).
Latest Insider Trading Transactions of Arch Venture Fund VII LP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MASS, AGIO, JUNO, RCPT, SAGE, SYRS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 180,578 | 0 | 0 | |
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 665,661 | 0 | 0 | |
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 669,977 | 0 | 0 | |
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 981,443 | 0 | 0 | |
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,927,386 | 0 | 0 | |
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Buy | P | 20.00 | 300,000 | 6,000,000 | 5,725,045 | 5.4 M to 5.7 M (+5.53 %) |
Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Buy | C | 0.00 | 5,425,045 | 0 | 5,425,045 | 0 to 5.4 M |
Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.70 | 34,521 | 265,687 | 4,242,051 | 4.3 M to 4.2 M (-0.81 %) |
Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.81 | 25,779 | 201,277 | 4,276,572 | 4.3 M to 4.3 M (-0.60 %) |
Jul 17 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.27 | 2,700 | 22,316 | 4,302,051 | 4.3 M to 4.3 M (-0.06 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.15 | 43,000 | 350,441 | 4,305,051 | 4.3 M to 4.3 M (-0.99 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 8.20 | 2,820 | 23,122 | 4,348,051 | 4.4 M to 4.3 M (-0.06 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.89 | 81,591 | 643,443 | 4,350,871 | 4.4 M to 4.4 M (-1.84 %) |
Mar 14 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 7.37 | 40,092 | 295,374 | 4,432,462 | 4.5 M to 4.4 M (-0.90 %) |
Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.49 | 44,878 | 291,366 | 4,472,554 | 4.5 M to 4.5 M (-0.99 %) |
Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.93 | 84,496 | 585,270 | 4,517,432 | 4.6 M to 4.5 M (-1.84 %) |
Mar 11 2019 | SYRS | Syros Pharmaceutic ... | ARCH Venture Fund VII, L.P. | 10% Owner | Sell | S | 6.87 | 35,209 | 242,013 | 4,601,928 | 4.6 M to 4.6 M (-0.76 %) |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,589,269 | 0 | 0 | |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | P | 12.50 | 400,000 | 5,000,000 | 4,637,137 | 4.2 M to 4.6 M (+9.44 %) |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 423,805 | 0 | 4,237,137 | 3.8 M to 4.2 M (+11.11 %) |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 2,000,000 | 0 | 3,813,332 | 1.8 M to 3.8 M (+110.29 %) |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,333,333 | 0 | 1,813,332 | 480 K to 1.8 M (+277.78 %) |
Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 266,666 | 0 | 479,999 | 213.3 K to 480 K (+125.00 %) |
Mar 17 2016 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 10,552,390 | 11.6 M to 10.6 M (-8.66 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,062,345 | 0 | 2,124,699 | 3.2 M to 2.1 M (-33.33 %) |
Feb 23 2015 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 386,074 | 0 | 3,088,590 | 3.5 M to 3.1 M (-11.11 %) |
Jan 16 2015 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,062,345 | 0 | 3,187,044 | 4.2 M to 3.2 M (-25.00 %) |
Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 3,747,500 | 0 | 0 | |
Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 6,250,000 | 0 | 0 | |
Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 457,875 | 0 | 11,552,390 | 11.1 M to 11.6 M (+4.13 %) |
Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 3,747,500 | 0 | 11,094,515 | 7.3 M to 11.1 M (+51.01 %) |
Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 6,250,000 | 0 | 7,347,015 | 1.1 M to 7.3 M (+569.73 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 885,583 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 281,137 | 0 | 4,249,389 | 4 M to 4.2 M (+7.08 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 2,380,951 | 0 | 3,968,252 | 1.6 M to 4 M (+150.00 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,587,301 | 0 | 1,587,301 | 0 to 1.6 M |
May 15 2014 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Sell | S | 28.39 | 7,907 | 224,480 | 2,058,634 | 2.1 M to 2.1 M (-0.38 %) |
May 15 2014 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Sell | S | 30.44 | 24,822 | 755,582 | 2,066,541 | 2.1 M to 2.1 M (-1.19 %) |
May 15 2014 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Sell | S | 28.72 | 10,013 | 287,573 | 2,091,363 | 2.1 M to 2.1 M (-0.48 %) |
May 15 2014 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Sell | S | 28.39 | 488 | 13,854 | 127,116 | 127.6 K to 127.1 K (-0.38 %) |
May 15 2014 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Sell | S | 30.44 | 1,535 | 46,725 | 127,604 | 129.1 K to 127.6 K (-1.19 %) |
May 15 2014 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Sell | S | 28.72 | 616 | 17,692 | 129,139 | 129.8 K to 129.1 K (-0.47 %) |
Jun 25 2014 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 386,074 | 0 | 3,474,664 | 3.9 M to 3.5 M (-10.00 %) |
Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 617,031 | 0 | 0 | |
Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
Jul 31 2013 | AGIO | AGIOS PHARMACEUTIC ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 3,860,738 | 0 | 3,860,738 | 0 to 3.9 M |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,102,426 | 0 | 0 | |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,667,124 | 0 | 0 | |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 973,165 | 0 | 0 | |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Buy | P | 14.00 | 284,485 | 3,982,790 | 2,101,376 | 1.8 M to 2.1 M (+15.66 %) |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 680,323 | 0 | 1,816,891 | 1.1 M to 1.8 M (+59.86 %) |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,022,283 | 0 | 1,136,568 | 114.3 K to 1.1 M (+894.50 %) |
May 14 2013 | RCPT | Receptos, Inc. | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 129,755 | 0 | 129,755 | 0 to 129.8 K |
Page: 1